Page last updated: 2024-11-07

spironolactone and Antopol Disease

spironolactone has been researched along with Antopol Disease in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research Excerpts

ExcerptRelevanceReference
"Heart failure is the main causes of morbidity and mortality."1.91Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy. ( Alcalai, R; Arad, M; Guetta, T; Hochhauser, E; Kornowski, R; Ofek, E; Petrover, Z; Seidman, CE; Seidman, J; Yadin, D, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yadin, D1
Guetta, T1
Petrover, Z1
Alcalai, R1
Seidman, J1
Seidman, CE1
Ofek, E1
Kornowski, R1
Hochhauser, E1
Arad, M1

Other Studies

1 other study available for spironolactone and Antopol Disease

ArticleYear
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy.
    Biochemical pharmacology, 2023, Volume: 215

    Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Genetic Therapy; Glycogen Storage Disease Type IIb;

2023
chemdatabank.com